 Anthony Gerber
Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 17 | 2025 | 138 | 4.790 |
Why?
| | Glucocorticoids | 13 | 2025 | 535 | 2.710 |
Why?
| | Dexamethasone | 10 | 2022 | 372 | 2.120 |
Why?
| | Asthma | 13 | 2026 | 1767 | 1.950 |
Why?
| | NF-kappa B | 12 | 2025 | 661 | 1.820 |
Why?
| | Transcription, Genetic | 10 | 2025 | 1496 | 1.800 |
Why?
| | Wood | 2 | 2026 | 21 | 1.620 |
Why?
| | Kruppel-Like Transcription Factors | 7 | 2020 | 78 | 1.620 |
Why?
| | Smoke | 2 | 2026 | 148 | 1.480 |
Why?
| | Muscle, Smooth | 4 | 2019 | 153 | 1.450 |
Why?
| | Nuclear Proteins | 6 | 2017 | 748 | 1.270 |
Why?
| | Enhancer Elements, Genetic | 5 | 2025 | 192 | 1.230 |
Why?
| | Gene Expression Regulation | 14 | 2025 | 2608 | 1.170 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2025 | 1217 | 1.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2026 | 459 | 1.090 |
Why?
| | Transcription Factors | 4 | 2022 | 1741 | 1.000 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 474 | 0.920 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2025 | 60 | 0.920 |
Why?
| | Epithelial Cells | 7 | 2026 | 1125 | 0.860 |
Why?
| | Airway Remodeling | 2 | 2017 | 64 | 0.850 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 4 | 2016 | 12 | 0.840 |
Why?
| | Alveolar Epithelial Cells | 2 | 2022 | 120 | 0.830 |
Why?
| | Particulate Matter | 2 | 2026 | 347 | 0.790 |
Why?
| | Transcription Factor RelA | 4 | 2025 | 85 | 0.770 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2026 | 2145 | 0.710 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 691 | 0.710 |
Why?
| | Mucin-5B | 3 | 2022 | 234 | 0.700 |
Why?
| | Signal Transduction | 11 | 2021 | 5226 | 0.690 |
Why?
| | Inflammation | 7 | 2026 | 2878 | 0.650 |
Why?
| | Cytokines | 5 | 2025 | 2061 | 0.610 |
Why?
| | Membrane Proteins | 1 | 2026 | 1166 | 0.600 |
Why?
| | Respiratory System | 2 | 2017 | 149 | 0.580 |
Why?
| | RNA | 2 | 2025 | 940 | 0.580 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 4 | 2026 | 920 | 0.570 |
Why?
| | Repressor Proteins | 2 | 2021 | 437 | 0.570 |
Why?
| | Bronchi | 3 | 2018 | 267 | 0.570 |
Why?
| | Proline Oxidase | 2 | 2015 | 6 | 0.560 |
Why?
| | Hyperoxia | 1 | 2019 | 99 | 0.550 |
Why?
| | Response Elements | 2 | 2015 | 89 | 0.530 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.530 |
Why?
| | Cell Line | 9 | 2025 | 2882 | 0.520 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.520 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1499 | 0.520 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 251 | 0.520 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 478 | 0.510 |
Why?
| | Lung | 9 | 2025 | 4109 | 0.500 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.460 |
Why?
| | Homeodomain Proteins | 2 | 2018 | 523 | 0.450 |
Why?
| | Triage | 1 | 2017 | 249 | 0.440 |
Why?
| | RNA, Messenger | 5 | 2025 | 2832 | 0.430 |
Why?
| | Genes, Reporter | 2 | 2017 | 275 | 0.400 |
Why?
| | Gene Expression | 3 | 2022 | 1490 | 0.390 |
Why?
| | Prednisolone | 1 | 2013 | 66 | 0.390 |
Why?
| | Humans | 48 | 2026 | 144759 | 0.380 |
Why?
| | Drug Discovery | 2 | 2016 | 155 | 0.380 |
Why?
| | Introns | 1 | 2014 | 254 | 0.380 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 209 | 0.380 |
Why?
| | A549 Cells | 5 | 2025 | 75 | 0.370 |
Why?
| | RNA Polymerase II | 5 | 2021 | 351 | 0.370 |
Why?
| | Chromatin | 3 | 2022 | 561 | 0.370 |
Why?
| | Binding Sites | 5 | 2021 | 1329 | 0.370 |
Why?
| | Genetic Predisposition to Disease | 4 | 2026 | 2363 | 0.360 |
Why?
| | Genomics | 3 | 2022 | 834 | 0.350 |
Why?
| | Machine Learning | 1 | 2017 | 585 | 0.350 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2026 | 79 | 0.330 |
Why?
| | Bronchial Hyperreactivity | 1 | 2011 | 96 | 0.320 |
Why?
| | Protein Binding | 6 | 2020 | 2273 | 0.290 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2017 | 139 | 0.290 |
Why?
| | I-kappa B Kinase | 3 | 2024 | 51 | 0.280 |
Why?
| | Models, Genetic | 2 | 2021 | 536 | 0.280 |
Why?
| | Vitamin D | 1 | 2011 | 400 | 0.280 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 2 | 2018 | 26 | 0.260 |
Why?
| | Interleukin-8 | 2 | 2026 | 271 | 0.260 |
Why?
| | Cells, Cultured | 5 | 2019 | 4154 | 0.260 |
Why?
| | Transcriptional Activation | 3 | 2016 | 383 | 0.260 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 266 | 0.250 |
Why?
| | Animals | 15 | 2026 | 38058 | 0.250 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 684 | 0.250 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2025 | 17 | 0.240 |
Why?
| | Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2025 | 4 | 0.230 |
Why?
| | Interferon Regulatory Factors | 1 | 2025 | 44 | 0.230 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2025 | 47 | 0.230 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 479 | 0.230 |
Why?
| | Systems Biology | 1 | 2006 | 72 | 0.230 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 1257 | 0.220 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2637 | 0.220 |
Why?
| | Base Sequence | 4 | 2017 | 2190 | 0.220 |
Why?
| | Lung Diseases | 2 | 2015 | 787 | 0.210 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 322 | 0.200 |
Why?
| | Mice | 8 | 2026 | 18339 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 338 | 0.190 |
Why?
| | Macrophages, Alveolar | 1 | 2026 | 368 | 0.190 |
Why?
| | Transposases | 1 | 2022 | 19 | 0.190 |
Why?
| | Afghanistan | 1 | 2022 | 96 | 0.180 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.180 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 37 | 0.170 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 140 | 0.170 |
Why?
| | alpha 1-Antitrypsin | 1 | 2022 | 102 | 0.170 |
Why?
| | Biological Therapy | 2 | 2022 | 28 | 0.170 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 148 | 0.170 |
Why?
| | Air Pollution | 1 | 2025 | 327 | 0.170 |
Why?
| | PPAR gamma | 1 | 2022 | 176 | 0.170 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 126 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 266 | 0.170 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.170 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 175 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.160 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 109 | 0.160 |
Why?
| | Primary Cell Culture | 2 | 2019 | 173 | 0.160 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 264 | 0.150 |
Why?
| | Corynebacterium Infections | 1 | 2020 | 42 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 207 | 0.150 |
Why?
| | Interleukin-1beta | 3 | 2025 | 395 | 0.140 |
Why?
| | Fluticasone | 1 | 2018 | 53 | 0.140 |
Why?
| | Gene Silencing | 2 | 2016 | 205 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 529 | 0.140 |
Why?
| | Histidine Decarboxylase | 1 | 2017 | 5 | 0.140 |
Why?
| | Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.140 |
Why?
| | Mucins | 1 | 2018 | 76 | 0.140 |
Why?
| | Drug Resistance | 1 | 2018 | 153 | 0.140 |
Why?
| | GATA2 Transcription Factor | 1 | 2017 | 14 | 0.130 |
Why?
| | Male | 10 | 2025 | 72315 | 0.130 |
Why?
| | Hypertrophy | 1 | 2017 | 127 | 0.130 |
Why?
| | Regeneration | 1 | 2019 | 197 | 0.130 |
Why?
| | Transduction, Genetic | 1 | 2017 | 133 | 0.130 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.120 |
Why?
| | Statistics as Topic | 1 | 2017 | 284 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2016 | 83 | 0.120 |
Why?
| | Adenoviridae | 1 | 2017 | 199 | 0.120 |
Why?
| | Trachea | 1 | 2018 | 261 | 0.120 |
Why?
| | Anaphylaxis | 1 | 2017 | 102 | 0.120 |
Why?
| | Mast Cells | 1 | 2017 | 146 | 0.120 |
Why?
| | Female | 9 | 2025 | 78271 | 0.120 |
Why?
| | Lung Injury | 1 | 2019 | 237 | 0.120 |
Why?
| | Models, Biological | 4 | 2016 | 1821 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2026 | 3121 | 0.110 |
Why?
| | Consensus | 1 | 2017 | 488 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2019 | 6429 | 0.110 |
Why?
| | Fibroblasts | 2 | 2025 | 1034 | 0.110 |
Why?
| | Administration, Inhalation | 1 | 2016 | 574 | 0.110 |
Why?
| | Interferon-gamma | 1 | 2018 | 784 | 0.110 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 87 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 442 | 0.110 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2015 | 91 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 675 | 0.110 |
Why?
| | Disease Progression | 2 | 2023 | 2847 | 0.110 |
Why?
| | Congresses as Topic | 1 | 2016 | 221 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 5960 | 0.100 |
Why?
| | RNA Interference | 1 | 2016 | 476 | 0.100 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 359 | 0.100 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 102 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 983 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 106 | 0.100 |
Why?
| | Muscle, Skeletal | 2 | 2015 | 1795 | 0.100 |
Why?
| | Blotting, Western | 1 | 2016 | 1187 | 0.100 |
Why?
| | Drug Monitoring | 1 | 2016 | 395 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2015 | 5992 | 0.100 |
Why?
| | Immunotherapy | 1 | 2017 | 653 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 318 | 0.090 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 138 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 549 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 457 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2020 | 635 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1782 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2018 | 928 | 0.080 |
Why?
| | Antibody Formation | 2 | 2022 | 294 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2930 | 0.080 |
Why?
| | Transcriptome | 1 | 2017 | 1045 | 0.080 |
Why?
| | Ovalbumin | 1 | 2011 | 190 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3540 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1837 | 0.080 |
Why?
| | Budesonide | 2 | 2022 | 49 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3409 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1519 | 0.070 |
Why?
| | Aurintricarboxylic Acid | 1 | 2009 | 4 | 0.070 |
Why?
| | Caproates | 1 | 2009 | 5 | 0.070 |
Why?
| | Toluidines | 1 | 2009 | 10 | 0.070 |
Why?
| | Rosaniline Dyes | 1 | 2009 | 15 | 0.070 |
Why?
| | Anthracyclines | 1 | 2009 | 47 | 0.070 |
Why?
| | Middle Aged | 2 | 2025 | 35875 | 0.070 |
Why?
| | Physicians | 1 | 2017 | 939 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 758 | 0.070 |
Why?
| | Adipogenesis | 1 | 2009 | 57 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 128 | 0.070 |
Why?
| | Biomarkers | 2 | 2017 | 4271 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2012 | 527 | 0.070 |
Why?
| | Antibodies, Viral | 2 | 2022 | 672 | 0.070 |
Why?
| | Autonomic Nervous System | 2 | 2005 | 79 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 863 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2009 | 329 | 0.060 |
Why?
| | Ligands | 1 | 2009 | 673 | 0.060 |
Why?
| | Haemophilus Infections | 1 | 2026 | 45 | 0.060 |
Why?
| | Haemophilus influenzae | 1 | 2026 | 67 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2182 | 0.060 |
Why?
| | Tobacco, Smokeless | 1 | 2005 | 13 | 0.060 |
Why?
| | DNA Methylation | 2 | 2022 | 681 | 0.050 |
Why?
| | Drug Therapy | 1 | 2005 | 80 | 0.050 |
Why?
| | Macrophages | 2 | 2022 | 1511 | 0.050 |
Why?
| | Disease | 1 | 2005 | 98 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 192 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2496 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2026 | 442 | 0.050 |
Why?
| | Environment | 1 | 2005 | 305 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 13 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 55 | 0.050 |
Why?
| | Phenotype | 2 | 2024 | 3162 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 51 | 0.050 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2005 | 186 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 59 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 383 | 0.040 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 395 | 0.040 |
Why?
| | Nicotine | 1 | 2005 | 331 | 0.040 |
Why?
| | Adult | 1 | 2025 | 40449 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2016 | 11679 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 374 | 0.040 |
Why?
| | Exercise | 1 | 2012 | 2201 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 983 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 573 | 0.040 |
Why?
| | Young Adult | 1 | 2016 | 14105 | 0.040 |
Why?
| | Corynebacterium | 1 | 2020 | 49 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 248 | 0.030 |
Why?
| | Th1 Cells | 1 | 2018 | 139 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | Smoking | 1 | 2005 | 1472 | 0.030 |
Why?
| | Transfection | 1 | 2020 | 940 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 183 | 0.030 |
Why?
| | Formoterol Fumarate | 1 | 2016 | 6 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 165 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 22428 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 336 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 315 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1463 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 358 | 0.030 |
Why?
| | Canada | 1 | 2017 | 428 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1732 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 641 | 0.030 |
Why?
| | Eosinophils | 1 | 2017 | 316 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2027 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1135 | 0.020 |
Why?
| | Vaccination | 1 | 2022 | 1423 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 732 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1489 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5597 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10779 | 0.020 |
Why?
| | United States | 2 | 2017 | 15966 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4557 | 0.020 |
Why?
| | Homeostasis | 1 | 2012 | 640 | 0.020 |
Why?
| | Amino Acids | 1 | 2012 | 521 | 0.020 |
Why?
| | Glucose | 1 | 2012 | 1047 | 0.020 |
Why?
| | Tachycardia | 1 | 2005 | 57 | 0.010 |
Why?
| | Biological Clocks | 1 | 2005 | 49 | 0.010 |
Why?
| | Tumor Escape | 1 | 2005 | 49 | 0.010 |
Why?
| | Vagus Nerve | 1 | 2005 | 91 | 0.010 |
Why?
| | Th2 Cells | 1 | 2005 | 171 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 178 | 0.010 |
Why?
| | Melatonin | 1 | 2005 | 163 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11787 | 0.010 |
Why?
| | Life Style | 1 | 2005 | 479 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 321 | 0.010 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2005 | 194 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2005 | 439 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2005 | 514 | 0.010 |
Why?
| | Child | 1 | 2018 | 22633 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 1109 | 0.010 |
Why?
| | Hypertension | 1 | 2005 | 1263 | 0.010 |
Why?
| | Neoplasms | 1 | 2005 | 2875 | 0.000 |
Why?
|
|
Gerber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|